Bharat Biotech Pursues COVID-19 Vaccine Approval In Over 40 Countries

Bharat Biotech is in the process of filing regulatory documents for approval of its COVID-19 vaccine, COVAXIN, in more than 40 countries, the company told Reuters late on Wednesday.